The Latest Psylo News

 
Featured
Dr. Sam Banister – Drug Development, Biotech, and Exploring Non-Hallucinogenic Compounds (PT491)
Dr. Sam Banister – Drug Development, Biotech, and Exploring Non-Hallucinogenic Compounds (PT491)
PSYLO's Next Generation Psychedelic Pipeline: An Interview with CSO and Co-founder Sam Banister
PSYLO's Next Generation Psychedelic Pipeline: An Interview with CSO and Co-founder Sam Banister
Psylo Celebrates Historic FDA Submission of MDMA-Assisted Therapy for PTSD by MAPS PBC
Psylo Celebrates Historic FDA Submission of MDMA-Assisted Therapy for PTSD by MAPS PBC
Next-Generation Psychedelics, Without the Hallucinations?
Next-Generation Psychedelics, Without the Hallucinations?
Biotechnology Start-Up Psylo Wins Hello Tomorrow APAC Deep Tech Competition in Singapore
Biotechnology Start-Up Psylo Wins Hello Tomorrow APAC Deep Tech Competition in Singapore
Psylo wins Hello Tomorrow APAC. Recap on One North Stories podcast with Dr Will Jorgensen
Psylo wins Hello Tomorrow APAC. Recap on One North Stories podcast with Dr Will Jorgensen
How are psychedelic drugs being used to treat mental illness and why is Australia a world leader in this space?- The Scan Podcast with Dr Dilara Bahceci
How are psychedelic drugs being used to treat mental illness and why is Australia a world leader in this space?- The Scan Podcast with Dr Dilara Bahceci
Psylo and Future Medicine - Humans of Purpose podcast with Dr Dilara Bahceci
Psylo and Future Medicine - Humans of Purpose podcast with Dr Dilara Bahceci
Lifting depression: Are hallucinations compulsory?
Lifting depression: Are hallucinations compulsory?
Dr Sam Banister presents “Psychedelics 2.0 and beyond” at EGA
Dr Sam Banister presents “Psychedelics 2.0 and beyond” at EGA
Psychedelic Biotech Strikes Big Pharma Agreement
Psychedelic Biotech Strikes Big Pharma Agreement
Australian startup Psylo advances depression treatment with Japanese pharma firm Daiichi Sankyo
Australian startup Psylo advances depression treatment with Japanese pharma firm Daiichi Sankyo
Psylo signs research deal with Daiichi Sankyo for psychiatric therapies
Psylo signs research deal with Daiichi Sankyo for psychiatric therapies
Psylo announces sponsored research agreement with Daiichi Sankyo to develop non-hallucinogenic psychiatric therapies
Psylo announces sponsored research agreement with Daiichi Sankyo to develop non-hallucinogenic psychiatric therapies
PSYLO ANNOUNCES SPONSORED RESEARCH AGREEMENT WITH DAIICHI SANKYO TO DEVELOP NON-HALLUCINOGENIC PSYCHIATRIC THERAPIES
PSYLO ANNOUNCES SPONSORED RESEARCH AGREEMENT WITH DAIICHI SANKYO TO DEVELOP NON-HALLUCINOGENIC PSYCHIATRIC THERAPIES
Australia’s food, drug and finance regulators can be progressive
Australia’s food, drug and finance regulators can be progressive
MDMA and Psilocybin are now legal in Australia
MDMA and Psilocybin are now legal in Australia
Timing is key for behavioural benefits of psychedelics
Timing is key for behavioural benefits of psychedelics
WTF is a head twitch? - Your Brain on Science Podcast with Dr Mario de la Fuente</a>
WTF is a head twitch? - Your Brain on Science Podcast with Dr Mario de la Fuente
Josh Ismin presents at Mind the Gap Seminar - Randwick Health &amp; Innovation Precinct (RHIP)
Josh Ismin presents at Mind the Gap Seminar - Randwick Health & Innovation Precinct (RHIP)
Psylo Awarded o2h Kickstarter
Psylo Awarded o2h Kickstarter
Raise The Bar Podcast with Josh Ismin
Raise The Bar Podcast with Josh Ismin
Webinar: Sam Banister, Chuck Nichols, and Dave Nichols
Webinar: Sam Banister, Chuck Nichols, and Dave Nichols
Australia leads world in psychedelics
Australia leads world in psychedelics
Psylo on the TGA rescheduling decision
Psylo on the TGA rescheduling decision
Psylo on 9news
Psylo on 9news
Renaissance in Psychedelic Therapy
Renaissance in Psychedelic Therapy
Psylo on Next Sequence
Psylo on Next Sequence
Psychedelics With Purpose
Psychedelics With Purpose
Seed funding announcement
Seed funding announcement